Predictors of hospitalisation and recovery following full antipsychotic discontinuation in first episode psychosis. A naturalistic retrospective cohort study

A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse

(2021) Mark Abie Horowitz et al.   SCHIZOPHRENIA BULLETIN

Long-term Continuity of Antipsychotic Treatment for Schizophrenia: A Nationwide Study

(2021) Jose M Rubio et al.   SCHIZOPHRENIA BULLETIN

Risk factors for psychotic relapse after dose reduction or discontinuation of antipsychotics in patients with chronic schizophrenia. A systematic review and meta-analysis

(2020) Jan P A M Bogers et al.   SCHIZOPHRENIA BULLETIN

Medication adherence in first episode psychosis: the role of pre‐onset subthreshold symptoms

(2019) J.‐G. Daneault et al.   ACTA PSYCHIATRICA SCANDINAVICA

20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia

(2018) Jari Tiihonen et al.   AMERICAN JOURNAL OF PSYCHIATRY

Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis

(2018) Taro Kishi et al.   PSYCHOLOGICAL MEDICINE

The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis

(2017) Melissa A Weibell et al.   SCHIZOPHRENIA BULLETIN

Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis

(2017) Toby T Winton-Brown et al.   SCHIZOPHRENIA RESEARCH

Medication-Adherent First-Episode Psychosis Patients Also Relapse: Why?

(2017) Emmanuelle Levy et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era

(2016) M. Alvarez-Jimenez et al.   CNS DRUGS

The relapse rate and predictors of relapse in patients with first-episode psychosis following discontinuation of antipsychotic medication

(2016) Suzanne Di Capite et al.   Early Intervention in Psychiatry

Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia

(2016) Wolfgang Gaebel et al.   SCHIZOPHRENIA RESEARCH

Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST)

(2016) Karin Landolt et al.   SCHIZOPHRENIA RESEARCH

Experiencing antipsychotic discontinuation: results from a survey of Australian consumers

(2014) C. Salomon et al.   Journal of Psychiatric and Mental Health Nursing

Antipsychotic Treatment and Mortality in Schizophrenia

(2014) M. Torniainen et al.   SCHIZOPHRENIA BULLETIN

Risk of symptom recurrence with medication discontinuation in first-episode psychosis: A systematic review

(2013) Robert B. Zipursky et al.   SCHIZOPHRENIA RESEARCH

Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy

(2013) Lex Wunderink et al.   JAMA Psychiatry

Pharmacotherapy challenges in patients with first-episode psychosis

(2012) Amal Abdel-Baki et al.   JOURNAL OF AFFECTIVE DISORDERS

Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

(2012) Stefan Leucht et al.   LANCET

A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia

(2011) Jari Tiihonen et al.   AMERICAN JOURNAL OF PSYCHIATRY

Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use

(2009) A. Gonzalez-Pinto et al.   SCHIZOPHRENIA BULLETIN

Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service

(2008) A. Malla et al.   PSYCHOLOGICAL MEDICINE